CervoMed (CRVO) EBIT Margin (2011 - 2025)
CervoMed (CRVO) posted EBIT Margin of -95479.25% for Q4 2025, down 95144.33 percentage points from -334.91% a year earlier and down 92985.45 percentage points from the prior quarter.
Powered by 
Analysis
CervoMed (CRVO) EBIT Margin (2011 - 2025) Analysis & Trends
For FY2025, CervoMed's EBIT Margin came in at -706.22%, down 519.05 percentage points from FY2024.
- In prior years, CervoMed's EBIT Margin was -187.18% in FY2024 (-77.83 pp) and -109.35% in FY2023.
- The Q4 2025 figure stands as the lowest quarterly EBIT Margin in data going back to Q3 2011.
- On a year-over-year basis, EBIT Margin has declined in each of the last eight quarters, with an average year-over-year change of -12272.28 percentage points over the last eight quarters.
- The year-over-year drop in EBIT Margin has ranged between 9.24 percentage points (Q1 2024) and 95144.33 percentage points (Q4 2025) over the last five years.
- According to Business Quant data, EBIT Margin for the three prior quarters was -2493.79% (Q3 2025), -376.41% (Q2 2025) and -276.55% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 28.37% |
| 10 | CervoMed | 23.87 Mn | -62.15 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -95,479.25% |
| Sep 30, 2025 | -2,493.79% |
| Jun 30, 2025 | -376.41% |
| Mar 31, 2025 | -276.55% |
| Dec 31, 2024 | -334.91% |
| Sep 30, 2024 | -278.19% |
| Jun 30, 2024 | -91.06% |
| Mar 31, 2024 | -110.55% |
| Dec 31, 2023 | -99.59% |
| Sep 30, 2023 | -175.25% |
| Jun 30, 2023 | -71.57% |
| Mar 31, 2023 | -101.31% |
| Jun 30, 2022 | -7,667.09% |
| Mar 31, 2022 | -16,377.61% |
| Sep 30, 2021 | -25,032.53% |
| Jun 30, 2021 | -6,940.68% |
| Mar 31, 2021 | -11,590.30% |
| Dec 31, 2020 | -16,341.08% |
| Sep 30, 2020 | -18,041.67% |
| Jun 30, 2020 | -14,118.25% |
API Access
CervoMed EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=CRVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "CRVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=CRVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();